H.C. Wainwright raised the firm’s price target on Avino Silver & Gold Mines to $2.20 from $1.90 and keeps a Buy rating on the shares ...

Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours trading after analysts at HC Wainwright reiterated their rating for the stock.

The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

H.C. Wainwright lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $50 from $75 and keeps a Buy rating on the shares. The firm ...

Alcoa (NYSE:AA – Free Report) had its price objective raised by HC Wainwright to $90.00 in a research note published on Tuesday morning,Stock Target Advisor reports. The firm currently has a buy ...

Fintel reports that on March 11, 2025, HC Wainwright & Co. downgraded their outlook for Checkpoint Therapeutics ...

Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...

Plug Power (Nasdaq: PLUG). From a high north of $3, shares of the hydrogen pioneer have been cut roughly in half, falling as ...

H.C. Wainwright downgraded Chimerix (CMRX) to Neutral from Buy after the company agreed to be acquired for $8.55 per share in cash by Jazz Pharmaceuticals (JAZZ). The total consideration of ...

Fintel reports that on March 7, 2025, HC Wainwright & Co. initiated coverage of Surf Air Mobility (NYSE:SRFM) with a Buy recommendation. As of March 4, 2025, the average one-year price target for ...

Fintel reports that on March 5, 2025, HC Wainwright & Co. initiated coverage of Intellia Therapeutics (LSE:0JBU) with a Buy recommendation. There are 572 funds or institutions reporting positions ...